Ozics website Ozics And The Future Of Mending Bones (written by Jennifer Hicks, Forbes contributor) The worldwide orthopedic market had global revenues of more than $36b in 2008. The market is dominated by six global companies that hold 80% of that global revenue. Osteoporosis has been on a relentless march. Worldwide, an osteoporotic fracture is estimated to occur every three seconds. Osteoporosis is estimated to affect 200 million women worldwide: approximately one-tenth of women aged 60, one-fifth of women aged 70, two-fifths of women aged 80 and two-thirds of women aged 90. Osteoporosis affects an estimated 75 million people in Europe, USA and Japan. And here is the statistic that demonstrates the size of the market potential for mending bones: by 2050, 30% of the EU population will be over the age of 65. * The Ozics Group, a Swiss biotech firm, believes it has found a way to manage osteoporosis with a newly discovered innovative material that is the perfect marriage of science and device design. The technology platform, known as Ozics CompO6™, enables minimally invasive transcutaneous repair of load-bearing fractures such as osteoporotic proximal femoral fracture...
Unlock the full article and exclusive OrthoStreams insights: in-depth analyses, hot startups, trends, market intel, and Daily Newsletter—for just $1/day.
Subscribe Now—Up your Game !

